|
gptkbp:instanceOf
|
gptkb:United_States_federal_law
|
|
gptkbp:administeredBy
|
gptkb:U.S._Department_of_Health_and_Human_Services
|
|
gptkbp:appliesTo
|
gptkb:United_States
|
|
gptkbp:approvedBy
|
emergency use of unapproved medical products
|
|
gptkbp:codifiedIn
|
Public Law 108-276
|
|
gptkbp:dateEnacted
|
July 21, 2004
|
|
gptkbp:enables
|
expedited research and development of countermeasures
government contracts with pharmaceutical companies
stockpiling of vaccines and treatments
|
|
gptkbp:enactedBy
|
gptkb:United_States_Congress
|
|
gptkbp:fundedBy
|
$5.6 billion over 10 years
|
|
gptkbp:provides
|
funding for the development and procurement of medical countermeasures
|
|
gptkbp:purpose
|
to provide protections and countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats
|
|
gptkbp:relatedLegislation
|
gptkb:21st_Century_Cures_Act
gptkb:Pandemic_and_All-Hazards_Preparedness_Act
|
|
gptkbp:relatedTo
|
public health emergency preparedness
bioterrorism
|
|
gptkbp:section
|
Homeland Security Act amendments
|
|
gptkbp:signedBy
|
gptkb:George_W._Bush
|
|
gptkbp:bfsParent
|
gptkb:Acts_of_the_108th_United_States_Congress
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Project BioShield Act
|